BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Kojin Therapeutics Debuts to Solve Difficult Diseases Through Cell Behavior

  Kojin launched with a $60 million Series A to focus on oncology and cell state biology led by Polaris Partners, Newpath Partners and Cathay Health.

  June 9, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Money on the Move: June 2-8

  Things are warming up quickly this summer for life sciences investors. Here’s who’s coming in hot with cash this week.

  June 9, 2021

   · 

  4 min read

   · 

  Kate Goodwin
• 

  Drug Development

  A Recent Flurry Of Biotech IPOs: Lyell, Atai, Alzamend and More

  The last few weeks have seen a flurry of filings for initial public offerings by biotech companies. Here’s a look.

  June 9, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Global Roundup: Sigrid Therapeutics Forges Manufacturing Agreement with Japan’s AGC

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  June 9, 2021

   · 

  5 min read

   · 

  Alex Keown
• 

  Business

  Genentech’s Dr. Charles Fuchs: “The Era of Personalized Cancer Care is Here”

  BioSpace caught up with Charles Fuchs, M.D., SVP, Global Head of Oncology & Hematology Product Development, Genentech during the ASCO meeting on personalized cancer care.

  June 9, 2021

   · 

  6 min read

   · 

  Gail Dutton
• 

  Business

  Let’s Get to Know Mir Imran, CEO and Chief Innovator at Rani Therapeutics

  BioSpace recently spoke with Mir Imran, CEO and Chief Innovator at Rani Therapeutics, a company developing and testing a “robotic” pill that delivers biologics orally.

  June 9, 2021

   · 

  5 min read

   · 

  Gina Hagler
• 

  Drug Development

  Bharat Biotech Plans Phase IV Study of Covaxin While Ocugen Eyes US EUA

  Bharat will conduct Phase IV studies to check real-world efficacy against the virus, while Ocugen says Covaxin will be a valuable tool in helping to end the COVID-19 pandemic.

  June 9, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  AbbVie Partners With Caraway to Develop Parkinson’s Disease Therapeutics

  The collaboration agreement will see the development and commercialization of the target, TMEM175 involved in Parkinson’s disease and other neurodegenerative conditions.

  June 9, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Business

  Data Companies Merge to Create Nation’s Largest Health Care Data Ecosystem

  The $7 billion transaction by Datavant with Ciox Health will be the nation’s largest “neutral and secure health data ecosystem.”

  June 9, 2021

   · 

  3 min read

   · 

  Kate Goodwin
• 

  Drug Development

  Some People May Have a Gene Variant that Protects Against COVID-19

  Newcastle University researchers identified a gene, HLA-DRB1*04:01, which was three times more common in asymptomatic COVID-19 patients than in people with symptomatic disease.

  June 9, 2021

   · 

  3 min read

   · 

  Mark Terry